Chronic exposure to NKG2D ligands expressed by monocytes downregulates the expression of NKG2D receptors on natural killer cells, preventing their ability to lyse NKG2D ligand‐expressing tumor cells 93. The gene discussed is KLRK1; the disease is neoplasm.